Critics Lead Gilead to Drop Coronavirus Drug Status

Image may be NSFW.
Clik here to view.

Gilead asked the U.S. Food and Drug Administration to designate remdesivir a so-called orphan drug, saying it qualified as a rare disease because fewer than 200,000 Americans are infected with the coronavirus.